Probiotics work the way drugs do — specifically or not at all. Solid trial support: certain strains (Lactobacillus rhamnosus GG, Saccharomyces boulardii) taken alongside antibiotics reduce antibiotic-associated diarrhea by roughly a third to half; some strains modestly improve IBS global symptoms and bloating; a specific L. reuteri strain helps breastfed-infant colic. Weak or absent: benefits for healthy people, "immune boosting," curing bloating universally, weight loss, mood, and repopulating after antibiotics (evidence even suggests some products delay natural recovery). Effects are strain-specific, end when dosing ends, and colonization is temporary. Generally safe — except in the severely immunocompromised and critically ill.
The question behind the question
"Do probiotics work?" bundles thousands of strains, dozens of conditions and one marketing category into a single verb. Unbundled — the only honest method, since Lactobacillus rhamnosus GG and a random yogurt culture share a genus the way humans and chimps do — the evidence sorts cleanly:
The scorecard
| Use | Verdict | What trials show |
|---|---|---|
| Antibiotic-associated diarrhea (adults & children) | Moderate | Meta-analyses: risk cut roughly 35–50% with S. boulardii or LGG taken during the course; the aisle's best-earned claim. |
| Infant colic (breastfed) | Limited-moderate | L. reuteri DSM 17938 reduced crying time in several RCTs; formula-fed results weaker. |
| IBS global symptoms & bloating | Limited | Some single strains beat placebo modestly; effects strain-specific, trials heterogeneous; guidelines suggest a 4-week single-product trial, stopped if silent. |
| Ulcerative colitis (adjunct, specific formulations) | Limited | Certain multi-strain formulations show adjunct benefit in mild disease and pouchitis — specialist territory. |
| Traveler's diarrhea prevention | Mixed | Pooled effects small and inconsistent. |
| "Restoring" flora after antibiotics | Mixed→caution | Landmark work found some products delayed return of native flora versus doing nothing; fiber and time won. |
| General "gut health" / regularity in the healthy | Insufficient | Trials in the healthy show transient microbiome guests and little symptomatic change. |
| Immunity, colds | Limited | Small trials suggest marginally fewer/shorter colds; effect sizes trivial per person. |
| Weight loss, mood ("psychobiotics"), skin | Insufficient | Pilot-scale, inconsistent, oversold. |
| Vaginal/urinary health | Mixed | Specific lactobacilli show some recurrence-prevention signals; product quality decisive. |
Two mechanics explain the pattern. Probiotics are visitors, not settlers — strains detectable while dosed, gone within weeks after — so trialled effects are treatment-length services, not renovations. And effects are strain- and formulation-specific, so a blend of ten untrialled strains inherits nothing from the table above, however impressive its CFU billboard (FAQ).
What the trials never tested
The marketing perimeter worth naming: microbiome "test-and-match" subscriptions (no guideline endorses stool-profile-directed probiotics), "detox/reset" framing, dose-escalation as potency, and — inherited from the wider industry — quality problems, with independent testing regularly finding products below label counts or containing off-label strains. Refrigeration and third-party verification (USP/NSF) sort some of it; strain names on the label (letters-and-numbers, e.g., DSM 17938) sort more, since sellers with trialled strains print them.
The honest playbook
- Antibiotics prescribed? The one routine-use case — FAQ timing, S. boulardii or LGG.
- IBS-pattern symptoms? After the diary-and-trigger work: one named-strain product, four weeks, scored, obeyed.
- General gut health? Fiber is the actual microbiome intervention with outcome evidence — feed residents rather than mailing visitors — plus fermented foods as the pleasant default (the fiber playbook doubles for this).
- Special populations — immunocompromised, pregnant with complications, infants — medical advice precedes any bottle.
- Red-flag symptoms — blood, weight loss, nocturnal symptoms, new change past 50 — are testing territory, which no probiotic postpones.
Product-level findings — which gut formulas name trialled strains and which sell CFU theater — live in gut supplement research.
Frequently asked questions
What do the CFU numbers mean, and is 100 billion better than 10?
Colony-forming units count live organisms per dose — and past the threshold a strain's trials used (often 1–10 billion), more has not shown more benefit. A 100-billion blend of untrialled strains loses, evidentially, to 5 billion of the exact strain a trial validated. CFUs are the aisle's horsepower number; strains are the engine.
Should I take probiotics with antibiotics, and when?
This is the best-supported use: start the probiotic the same day as the antibiotic (separated by a couple of hours), continue through the course and a week after; S. boulardii (a yeast, indifferent to antibiotics) or LGG are the studied picks. One nuance from newer research: for restoring your own flora after the course, plain time and a fiber-rich diet perform well, and some multi-strain products actually slowed that reconstitution.
Are fermented foods just as good?
Different and arguably better as a habit: yogurt, kefir, curd, kimchi and kraut deliver live organisms plus food matrix, and cohort-plus-small-trial evidence links fermented-food patterns to favorable microbiome and inflammation markers — without strain-level claims. They are the sensible default for general gut health; supplements exist for the specific, trialled jobs.
Can probiotics be harmful?
For healthy people, rarely — gas early on is the usual toll. Real caution belongs to the severely immunocompromised, critically ill, those with central venous catheters, and premature infants outside medical protocols — bloodstream infections from probiotic organisms are documented in exactly these groups. Anyone in them: medical sign-off first, not shelf advice.
References
- NCCIH. Probiotics: What You Need To Know (2019). https://www.nccih.nih.gov/health/probiotics-what-you-need-to-know
- NIDDK. Gas in the Digestive Tract (2021). https://www.niddk.nih.gov/health-information/digestive-diseases/gas-digestive-tract
- U.S. Food and Drug Administration. Dietary Supplements (2024). https://www.fda.gov/food/dietary-supplements
This page discusses supplement ingredients or categories. It may mention a commercial product, with disclosure. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.